Cardi Maurizio, Sibio Simone, Di Marzo Francesco, Lefoche Francesco, d'Agostino Claudia, Fonsi Giovanni Battista, La Torre Giuseppe, Carbonari Ludovica, Sammartino Paolo
Dipartimento di Chirurgia Pietro Valdoni, Sapienza Università di Roma, Viale del Policlinico 155, 00161 Roma, Italy.
Chirurgia Generale, Ospedale Versilia, Via Aurelia 335, 55041 Lido di Camaiore, Italy.
Gastroenterol Res Pract. 2019 May 2;2019:2824073. doi: 10.1155/2019/2824073. eCollection 2019.
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) showed promising results in selected patients. High morbidity restrains its wide application. The aim of this study was to report postoperative infectious complications and investigate possible correlations with the preoperative nutritional status and other prognostic factors in patients with peritoneal metastases treated with CRS and HIPEC.
For the study, we reviewed the clinical records of all patients with peritoneal metastases from different primary cancers treated with CRS and HIPEC in our Institution from November 2000 to December 2017. Patients were divided according to their nutritional status (SGA) into groups A (well-nourished) and B/C (mild or severely malnourished, respectively). Possible statistical correlations between risk factors and postoperative complication rates have been investigated by univariate and multivariate analysis.
Two hundred patients were selected and underwent CRS and HIPEC during the study period. Postoperative complications occurred in 44% of the patients, 35.3% in SGA-A patients, and 53% in SGA-B/C patients. Cause of complications was infective in 42, noninfective in 37, and HIPEC related in 9 patients. Infectious complications occurred more frequently in SGA-B/C patients (32.6% vs. 9.8% of SGA-A patients). The most frequent sites of infection were surgical site infections (SSI, 35.7%) and central line-associated bloodstream infections (CLABSI, 26.2%). The most frequent isolated species was Candida (22.8%). ASA score, blood loss, performance status, PCI, large bowel resection, postoperative serum albumin levels, and nutritional status correlated with higher risk for postoperative infectious complications.
Malnourished patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy are more prone to postoperative infectious complications, and adequate perioperative nutritional support should be considered, including immune-enhancing nutrition. Sequential monitoring of common sites of infection, antifungal prevention of candidiasis, and careful patient selection should be implemented to reduce the complication rate.
细胞减灭术(CRS)和腹腔内热灌注化疗(HIPEC)在部分患者中显示出了良好的效果。高发病率限制了其广泛应用。本研究的目的是报告接受CRS和HIPEC治疗的腹膜转移患者术后感染性并发症,并探讨其与术前营养状况及其他预后因素之间可能存在的相关性。
本研究回顾了2000年11月至2017年12月期间在我院接受CRS和HIPEC治疗的所有不同原发癌腹膜转移患者的临床记录。根据营养状况(主观全面评定法,SGA)将患者分为A组(营养良好)和B/C组(分别为轻度或重度营养不良)。通过单因素和多因素分析研究危险因素与术后并发症发生率之间可能存在的统计学相关性。
研究期间共选取200例患者接受CRS和HIPEC治疗。44%的患者发生术后并发症,SGA - A组患者为35.3%,SGA - B/C组患者为53%。并发症原因中,42例为感染性,37例为非感染性,9例与HIPEC相关。SGA - B/C组患者感染性并发症发生率更高(32.6% vs. SGA - A组患者的9.8%)。最常见的感染部位是手术部位感染(SSI,35.7%)和中心静脉导管相关血流感染(CLABSI,26.2%)。最常见的分离菌种是念珠菌(22.8%)。美国麻醉医师协会(ASA)评分、失血量、体能状态、腹膜癌指数(PCI)、大肠切除术、术后血清白蛋白水平和营养状况与术后感染性并发症的较高风险相关。
接受细胞减灭术和腹腔内热灌注化疗的营养不良患者更容易发生术后感染性并发症,应考虑给予充分的围手术期营养支持,包括免疫增强营养。应连续监测常见感染部位,预防性抗真菌治疗念珠菌感染,并谨慎选择患者以降低并发症发生率。